title: Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire.
abstract: Few studies have examined the subjective value attributed to drug rewards specifically as it compares with the value attributed to primary non-drug rewards in addicted individuals. The objective of this study is to assess 'liking' and 'wanting' of expected 'drug' rewards as compared to 'food' and 'sex' while respondents report about three different situations ('current', and hypothetical 'in general', and 'under drug influence'). In all, 20 cocaine-addicted individuals (mean abstinence = 2 days) and 20 healthy control subjects were administered the STRAP-R (Sensitivity To Reinforcement of Addictive and other Primary Rewards) questionnaire after receiving an oral dose of the dopamine agonist methylphenidate (20 mg) or placebo. The reinforcers' relative value changed within the addicted sample when reporting about the 'under drug influence' situation (drug > food; otherwise, drug < food). This change was highest in the addicted individuals with the youngest age of cocaine use onset. Moreover, 'drug' 'wanting' exceeded 'drug' 'liking' in the addicted subjects when reporting about this situation during methylphenidate. Thus, cocaine-addicted individuals assign the highest subjective valence to 'drug' rewards but only when recalling cue-related situations. When recalling this situation, they also report higher 'drug' 'wanting' than hedonic 'liking', a motivational shift that was only significant during methylphenidate. Together, these valence shifts may underlie compulsive stimulant abuse upon pharmacological or behavioural cue exposure in addicted individuals. Additional studies are required to assess the reliability of the STRAP-R in larger samples and to examine its validity in measuring the subjective value attributed to experienced reinforcers or in predicting behaviour.
authors.affiliation: Department of Medical Research, Center for Translational Neuroimaging, Brookhaven National Laboratory, Upton, NY 11973-5000, USA. rgoldstein@bnl.gov
authors.forename: R Z
authors.initials: RZ
authors.lastname: Goldstein
authors.forename: P A
authors.initials: PA
authors.lastname: Woicik
authors.forename: S J
authors.initials: SJ
authors.lastname: Moeller
authors.forename: F
authors.initials: F
authors.lastname: Telang
authors.forename: M
authors.initials: M
authors.lastname: Jayne
authors.forename: C
authors.initials: C
authors.lastname: Wong
authors.forename: G J
authors.initials: GJ
authors.lastname: Wang
authors.forename: J S
authors.initials: JS
authors.lastname: Fowler
authors.forename: N D
authors.initials: ND
authors.lastname: Volkow
mesh_terms: D000328:Adult; D017668:Age of Onset; D016739:Behavior, Addictive / Q000523:psychology*; D016022:Case-Control Studies; D019970:Cocaine-Related Disorders / Q000523:psychology*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology; D008875:Middle Aged; D009042:Motivation; D011594:Psychometrics; D012201:Reward; D011795:Surveys and Questionnaires
chemical_list: D018765:Dopamine Uptake Inhibitors; D008774:Methylphenidate
references.citation: Addiction. 1999 Mar;94(3):327-40
references.pmid: 10605857
references.citation: Addiction. 2001 Jan;96(1):103-14
references.pmid: 11177523
references.citation: J Am Med Assoc. 1955 Mar 19;157(12):1006-20
references.pmid: 14353639
references.citation: Neuropsychologia. 2002;40(10):1690-705
references.pmid: 11992657
references.citation: Science. 1991 Mar 29;251(5001):1580-6
references.pmid: 2011738
references.citation: J Neurosci. 2003 Feb 1;23(3):742-7
references.pmid: 12574402
references.citation: Psychopharmacology (Berl). 1999 Feb;142(1):31-40
references.pmid: 10102780
references.citation: Psychopharmacology (Berl). 1999 Feb;142(2):200-8
references.pmid: 10102773
references.citation: J Neurosci. 2006 Jun 14;26(24):6583-8
references.pmid: 16775146
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
references.pmid: 12402102
references.citation: Nature. 1997 Apr 24;386(6627):827-30
references.pmid: 9126740
references.citation: J Pharmacol Exp Ther. 1985 Dec;235(3):677-82
references.pmid: 4078729
references.citation: Annu Rev Psychol. 2003;54:25-53
references.pmid: 12185211
references.citation: Exp Clin Psychopharmacol. 1997 Aug;5(3):256-62
references.pmid: 9260073
references.citation: Behav Neurosci. 2005 Dec;119(6):1619-27
references.pmid: 16420164
references.citation: Physiol Behav. 2007 Jan 30;90(1):36-42
references.pmid: 17052736
references.citation: J Am Med Assoc. 1955 Mar 26;157(13):1113-9
references.pmid: 14353650
references.citation: Am J Psychiatry. 2000 Nov;157(11):1789-98
references.pmid: 11058476
references.citation: J Neurosci. 2001 Oct 1;21(19):7831-40
references.pmid: 11567074
references.citation: Behav Neurosci. 2002 Apr;116(2):321-33
references.pmid: 11996317
references.citation: Am J Psychiatry. 2004 Jul;161(7):1173-80
references.pmid: 15229048
references.citation: J Neurosci. 2006 May 31;26(22):5881-7
references.pmid: 16738229
references.citation: Psychopharmacology (Berl). 2000 Oct;152(2):140-8
references.pmid: 11057517
references.citation: Am J Psychiatry. 1998 Oct;155(10):1325-31
references.pmid: 9766762
references.citation: Am J Psychiatry. 1999 Jan;156(1):19-26
references.pmid: 9892293
references.citation: Addiction. 2006 May;101(5):713-25
references.pmid: 16669905
references.citation: Psychopharmacology (Berl). 1992;107(4):523-9
references.pmid: 1603895
references.citation: Am J Psychiatry. 2002 Oct;159(10):1642-52
references.pmid: 12359667
references.citation: Am J Psychiatry. 1999 Sep;156(9):1440-3
references.pmid: 10484959
references.citation: J Stud Alcohol. 1994 Mar;55(2):224-9
references.pmid: 8189743
references.citation: Addict Behav. 1992 Sep-Oct;17(5):491-9
references.pmid: 1332435
references.citation: Arch Gen Psychiatry. 2002 Dec;59(12):1162-72
references.pmid: 12470133
references.citation: NIDA Res Monogr. 1993;135:15-30
references.pmid: 8289894
references.citation: J Neurosci. 2003 Dec 10;23(36):11461-8
references.pmid: 14673011
references.citation: Behav Brain Res. 2002 Jan 22;128(2):189-203
references.pmid: 11796164
references.citation: Synapse. 2002 Jun 1;44(3):175-80
references.pmid: 11954049
references.citation: Addiction. 2005 Oct;100(10):1487-95
references.pmid: 16185210
references.citation: J Subst Abuse Treat. 1994 Nov-Dec;11(6):549-52
references.pmid: 7884838
references.citation: Nat Neurosci. 2002 Jul;5(7):625-6
references.pmid: 12055635
references.citation: Psychopharmacology (Berl). 2005 Apr;178(4):493-9
references.pmid: 15517194
references.citation: J Neurosci. 1999 Jan 1;19(1):456-63
references.pmid: 9870973
references.citation: Pharmacol Biochem Behav. 2005 Sep;82(1):90-7
references.pmid: 16112720
references.citation: Drug Alcohol Depend. 2007 Mar 16;87(2-3):233-40
references.pmid: 16997508
references.citation: Science. 1998 Oct 9;282(5387):298-300
references.pmid: 9765157
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Psychoneuroendocrinology. 2005 Oct;30(9):880-91
references.pmid: 15975729
references.citation: Drug Alcohol Depend. 1997 Mar 14;44(2-3):87-94
references.pmid: 9088780